← FDA Drug Approvals (Drugs@FDA)

IVERMECTIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2019-09-13

Drug application

FDA Application #

ANDA210019

Application type

Abbreviated New Drug Application (Generic)

Brand name

IVERMECTIN

Generic name

IVERMECTIN

Active ingredients

IVERMECTIN

Dosage form

CREAM

Route

TOPICAL

Marketing status

Prescription

Sponsor

TEVA PHARMS USA

Manufacturer

Actavis Pharma, Inc.

First approval

2019-09-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown